Effects of different levels of testosterone on the coagulative and fibrinolytic systems of male rabbits

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 7, 2005, Pages 85-87

  Si, Quan Jin ^a   Li, Xiao Ying ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA 2 ANTIPLASMIN; D DIMER; ESTRADIOL; FIBRINOGEN; PLASMINOGEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CASTRATION; CONTROLLED STUDY; FIBRINOLYSIS; HORMONE DEFICIENCY; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RABBIT; STATISTICAL ANALYSIS;

EID: 20544461906     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chinese source. 2004,8(9):1672-3
2. Chinese source. 2004,8(6):1150-13
3. Chinese source. 2003,7(24):3288-9
4. English KM, Mandour O, Steeds RP, et al. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 2000; 21:890-4
5. Berg G, Schreier L, Geloso G, et al. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men. Horm Metab Res 2002;34:87-92
6. Zaoui M, Cordebar B, Sommer S. Central retinal vein occlusion in a patient treated with antiandrogenic drug. J Fr Ophtalmol 2000; 23(1): 42-4
7. Nako J. Testosterone inhibits prostocyclin production by rat aortic smooth muscle cells in culure. Atherosclerosis 1981; 39:203-9
8. Ferenchick GS, Hirokawa S, Mammen EF, et al. Anabolic-androgenic steroid abuse in weight lifters: evidence for activation of the hemostatic system. Am J Hematol 1995;49(4):282-8
9. Alvarado RG, Liu JY, Zwolak RM. Danazol and limb-threatening arterial thrombosis: two case reports. J Vasc Surg 2001;34(6):1123-6
10. Winkler UH. Effects of androgens on haemostasis. Maturitas 1996;24(3):147-55
11. De-Pergola G, De-Mitrio V, Sciaraffia M, et al. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism 1997; 46 (11): 1287-93
12. Yildiz BO, Haznedaroglu IC, Kirazli S, et al. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab 2002;87:3871-5
13. Rosano GMC. Androgen and coronary artery disease, a sex-specific effect of sex hormones? Eur Heart J 2000;21:868-71